“We are maintaining our MARKET PERFORM investment rating on USPH shares. While we really like this business and think its leadership is among the best we have seen in healthcare services, the stock’s current valuation is higher than we can ever recall in our 14 years of covering this idea. We would certainly reconsider our investment rating if shares were to weaken a bit.”,” Barrington Research’s analyst commented.
Other research analysts have also recently issued research reports about the stock. Cantor Fitzgerald reiterated a buy rating and set a $80.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, January 9th. Zacks Investment Research cut shares of U.S. Physical Therapy from a buy rating to a hold rating in a research report on Friday. Finally, Jefferies Group set a $76.00 price objective on shares of U.S. Physical Therapy and gave the company a hold rating in a research report on Friday, February 23rd. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of Hold and a consensus price target of $79.40.
U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Thursday, March 8th. The company reported $0.49 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.49. U.S. Physical Therapy had a net margin of 5.38% and a return on equity of 13.12%. The business had revenue of $109.20 million for the quarter, compared to analysts’ expectations of $104.12 million. equities research analysts expect that U.S. Physical Therapy will post 2.39 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 13th. Stockholders of record on Wednesday, March 21st will be issued a $0.23 dividend. The ex-dividend date is Tuesday, March 20th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.20. This represents a $0.92 dividend on an annualized basis and a dividend yield of 1.08%. U.S. Physical Therapy’s dividend payout ratio is presently 55.94%.
In other news, CFO Lawrance W. Mcafee sold 5,000 shares of the company’s stock in a transaction dated Friday, March 9th. The shares were sold at an average price of $83.35, for a total value of $416,750.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Mark J. Brookner sold 2,625 shares of the company’s stock in a transaction dated Wednesday, December 27th. The stock was sold at an average price of $71.23, for a total transaction of $186,978.75. The disclosure for this sale can be found here. Corporate insiders own 3.10% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. grew its holdings in shares of U.S. Physical Therapy by 2.5% in the fourth quarter. BlackRock Inc. now owns 1,621,087 shares of the company’s stock worth $117,043,000 after purchasing an additional 40,093 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of U.S. Physical Therapy by 1.5% in the third quarter. Dimensional Fund Advisors LP now owns 493,972 shares of the company’s stock worth $30,355,000 after purchasing an additional 7,197 shares during the last quarter. State Street Corp grew its holdings in shares of U.S. Physical Therapy by 3.8% in the second quarter. State Street Corp now owns 319,307 shares of the company’s stock worth $19,286,000 after purchasing an additional 11,645 shares during the last quarter. BTIM Corp. grew its holdings in shares of U.S. Physical Therapy by 0.7% in the fourth quarter. BTIM Corp. now owns 280,557 shares of the company’s stock worth $20,256,000 after purchasing an additional 1,952 shares during the last quarter. Finally, Fred Alger Management Inc. grew its holdings in shares of U.S. Physical Therapy by 1.4% in the fourth quarter. Fred Alger Management Inc. now owns 237,609 shares of the company’s stock worth $17,155,000 after purchasing an additional 3,296 shares during the last quarter. Hedge funds and other institutional investors own 96.53% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://sportsperspectives.com/2018/03/13/u-s-physical-therapy-usph-given-hold-rating-at-barrington-research.html.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.